Orth Andrew C.insider trades

In SEC Form 4 filings, Orth Andrew C. is listed as President & CEO of City Therapeutics, Inc. (CTY). Orth Andrew C. reported no open-market purchases or sales in the last 90 days. The latest Form 4 transaction on record was filed on Oct 19.

Companies and roles

Company	Role	Transactions	Last filed
CTYCity Therapeutics, Inc.	President & CEO	1	Oct 19

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-10-19

Company	Traded	Filed	Type	Shares	Price	Value	Owned after	10b5-1 plan	Filing
CTYCity Therapeutics, Inc.	Oct 19	Oct 19	A · derivative	77,979	$0.92	$71,741	77,979	No	Form 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.